A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer

A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer is a phase 2, interventional study registered as NCT05939661 by Osaka University, with a registry enrolment figure of 45 participants, started 2023-05-25 and due to reach its primary completion in 2026-03-31. Interventions recorded: Radiation; Chemotherapy; Surgery. Conditions listed: Rectal Cancer. Primary outcome: Pathological complete response (pCR). Colorectal eligibility wording from the registry: "The patient has adenocarcinoma of the rectum confirmed by histological examination". Sites: Japan. No results are recorded here; the registry entry is the source.